perioperative management of glp-1 agonists receptor like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) have become incredibly common in diabetes and weight-management care, and they're now showing up more and more in the setting. These π¬π§ Perioperative Management of New
Description
However, individual responses to Tirzepatide can vary based on several factors, including dosage, adherence to the prescribed regimen, lifestyle changes, and individual metabolic differences
In addition, few studies currently support the use of GLP-1RAs in patients with HFrEF
Acta Crystallogr
You also have side effects
Effect of semaglutide 2.4 mg once weekly on 10-year type 2 diabetes risk in adults with overweight or obesity
